Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06591377 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 18, 2025 (before its estimated September 19, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Feb 1, 2022 to Aug 10, 2024v3
  2. Primary completion date: Sep 19, 2024 to Sep 19, 2025v2 Show 4 more changesShow less
    • Study sites: 1 to 2
    • Study completion date: Oct 1, 2024 to Oct 1, 2025
    • Interventions: Cilostazol 100 MG (Drug), Ticagrelor 90 MG (Drug) to Aspirin 75mg (Drug), Aspirin 75mg (Drug), Cilostazol 100 MG (Drug), Ticagrelor 90 MG (Drug)
    • Collaborators expanded, about 3 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Kafrelsheikh University
152 trials monitored
See 1 trial at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.
Trial Details
NCT Number NCT06591377
Lead Sponsor Kafrelsheikh University
Collaborators: El-Sahel Teaching Hospital
Conditions
(from sponsor)		 Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 900 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov